Oxler Private Wealth’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Oxler Private Wealth's IBB Position: Q3 2026 in Review
Oxler Private Wealth reduced its iShares Biotechnology ETF (IBB) stake by 3.8% in Q3 2026, selling an estimated $12.2K and leaving 1,536 shares worth $323K. The position accounts for 0.09% of the portfolio, ranked #71.
Oxler Private Wealth first reported a position in IBB in Q4 2020 and has held it in 24 quarters since. The position peaked at $784K in Q3 2021. 907 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Oxler Private Wealth held 1,536 shares of iShares Biotechnology ETF worth $323K as of Q3 2026.
- Oxler Private Wealth sold 61 iShares Biotechnology ETF shares in Q3 2026, an estimated $12.2K.
- iShares Biotechnology ETF made up 0.09% of Oxler Private Wealth's portfolio in Q3 2026, its #71 holding.
- Oxler Private Wealth first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 24 quarters since.
- Oxler Private Wealth's iShares Biotechnology ETF position peaked at $784K in Q3 2021.
- 907 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Oxler Private Wealth's 13F filing for Q3 2026, filed 21 Oct 2026.